Relay Therapeutics, Inc. (RLAY)
$17.88+2.70%Close
SELLRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.1B
- Beta
- 1.73
- P/E (TTM)
- -11.94
- Short % float
- 34.34%
- Days to cover
- 12.6
- SI change
- +5.1%
- 1W
- -5.70%
- 1M
- -5.35%
- vs SPY 1W
- -6.86%
- vs SPY 1M
- -8.34%
Industry peers
FMP comparable companies · ranked by market cap
- RVMDSELLRevolution Medicines, Inc.$42.5BRECOVERYQ 30$199.87+0.87%
- KYMRSELLKymera Therapeutics, Inc.$8.7BBEARQ 25$105.98+2.84%
- ERASSELLErasca, Inc.$5.0BRECOVERYQ 4$14.30+3.69%
- TNGXSELLTango Therapeutics, Inc.$3.6BRECOVERYQ 24$21.90+5.49%
- IDYASELLIDEAYA Biosciences, Inc.$3.5BBEARQ 25$36.63+0.14%
- NRIXSELLNurix Therapeutics, Inc.$2.3BBEARQ 11$22.60+0.63%
- ORICSELLORIC Pharmaceuticals, Inc.$1.2BBEARQ 3$11.98-0.33%
- TYRASELLTyra Biosciences, Inc.$1.2BCRISISQ 5$20.24-0.15%
- AVBPSELLArriVent BioPharma, Inc.$703MCRISISQ -5$15.09+0.12%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 5
- GROWTH
- 4
- GARP
- 3
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-25.4%
REV YoY-
ROE-42.3%
EPS YoY-
ROA-29.6%
GROSS-567
OP-2999
NET-2764
[VALUATION]
P/E TTM-11.94
P/E FWD-
SECTOR PE20.47
INDUSTRY PE13.95
P/B4.27
P/FCF-
EV/EBITDA-14.00
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E3.44
ALTMAN Z-
CURR RATIO18.27
ND/EBITDA-
BETA1.73
